CN103508984B - 连续浸漉吸附富集法从红豆杉中提取10-dab的方法 - Google Patents
连续浸漉吸附富集法从红豆杉中提取10-dab的方法 Download PDFInfo
- Publication number
- CN103508984B CN103508984B CN201310501147.4A CN201310501147A CN103508984B CN 103508984 B CN103508984 B CN 103508984B CN 201310501147 A CN201310501147 A CN 201310501147A CN 103508984 B CN103508984 B CN 103508984B
- Authority
- CN
- China
- Prior art keywords
- dab
- leaves
- branches
- resin
- adsorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 52
- 238000001179 sorption measurement Methods 0.000 title claims abstract description 37
- 239000000284 extract Substances 0.000 title claims abstract description 20
- YWLXLRUDGLRYDR-UHFFFAOYSA-N 10-deacetylbaccatin Chemical compound CC(=O)OC12COC1CC(O)C(C(C(O)C1=C(C)C(O)CC3(O)C1(C)C)=O)(C)C2C3OC(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-UHFFFAOYSA-N 0.000 title claims description 114
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 title abstract description 15
- 239000011347 resin Substances 0.000 claims abstract description 54
- 229920005989 resin Polymers 0.000 claims abstract description 54
- 238000002386 leaching Methods 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000012043 crude product Substances 0.000 claims abstract description 22
- 239000003960 organic solvent Substances 0.000 claims abstract description 18
- 238000006698 hydrazinolysis reaction Methods 0.000 claims abstract description 11
- 239000004519 grease Substances 0.000 claims abstract description 5
- 239000007787 solid Substances 0.000 claims abstract description 5
- 239000002253 acid Substances 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims description 32
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 28
- 239000007864 aqueous solution Substances 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 25
- 239000002250 absorbent Substances 0.000 claims description 16
- 230000002745 absorbent Effects 0.000 claims description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 238000002791 soaking Methods 0.000 claims description 15
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 230000002378 acidificating effect Effects 0.000 claims description 12
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000012544 monitoring process Methods 0.000 claims description 9
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 229960000583 acetic acid Drugs 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000012044 organic layer Substances 0.000 claims description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 claims 1
- 241001116500 Taxus Species 0.000 abstract description 16
- 238000000605 extraction Methods 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 8
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 abstract description 2
- 238000001556 precipitation Methods 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 description 18
- 229960001592 paclitaxel Drugs 0.000 description 17
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 7
- 241001116498 Taxus baccata Species 0.000 description 7
- 229960003668 docetaxel Drugs 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 229940123237 Taxane Drugs 0.000 description 5
- BMQGVNUXMIRLCK-OAGWZNDDSA-N cabazitaxel Chemical compound O([C@H]1[C@@H]2[C@]3(OC(C)=O)CO[C@@H]3C[C@@H]([C@]2(C(=O)[C@H](OC)C2=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=3C=CC=CC=3)C[C@]1(O)C2(C)C)C)OC)C(=O)C1=CC=CC=C1 BMQGVNUXMIRLCK-OAGWZNDDSA-N 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 241001674343 Taxus x media Species 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- DBXFAPJCZABTDR-KUEXGRMWSA-N Cephalomannine Natural products O=C(O[C@@H]1C(C)=C2[C@@H](OC(=O)C)C(=O)[C@]3(C)[C@@H](O)C[C@@H]4[C@](OC(=O)C)([C@H]3[C@H](OC(=O)c3ccccc3)[C@@](O)(C2(C)C)C1)CO4)[C@@H](O)[C@H](NC(=O)/C(=C\C)/C)c1ccccc1 DBXFAPJCZABTDR-KUEXGRMWSA-N 0.000 description 3
- 244000050510 Cunninghamia lanceolata Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229960001573 cabazitaxel Drugs 0.000 description 3
- DBXFAPJCZABTDR-WBYYIXQISA-N cephalomannine Chemical compound O([C@@H]1[C@]2(O)C[C@@H](C(=C([C@@H](OC(C)=O)C(=O)[C@]3(C)[C@@H](O)C[C@H]4OC[C@]4([C@H]31)OC(C)=O)C2(C)C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C(/C)=C/C)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 DBXFAPJCZABTDR-WBYYIXQISA-N 0.000 description 3
- 229960003487 xylose Drugs 0.000 description 3
- -1 10-DAB Chemical compound 0.000 description 2
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 description 2
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- 240000001417 Vigna umbellata Species 0.000 description 2
- 235000011453 Vigna umbellata Nutrition 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 229940025735 jevtana Drugs 0.000 description 2
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241001248537 Eurema daira Species 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 235000011609 Pinus massoniana Nutrition 0.000 description 1
- 241000018650 Pinus massoniana Species 0.000 description 1
- 235000016408 Podocarpus macrophyllus Nutrition 0.000 description 1
- 241001116495 Taxaceae Species 0.000 description 1
- 244000162450 Taxus cuspidata Species 0.000 description 1
- 235000009065 Taxus cuspidata Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 229930014667 baccatin III Natural products 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229950005692 larotaxel Drugs 0.000 description 1
- SEFGUGYLLVNFIJ-QDRLFVHASA-N larotaxel dihydrate Chemical compound O.O.O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@@]23[C@H]1[C@@]1(CO[C@@H]1C[C@@H]2C3)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 SEFGUGYLLVNFIJ-QDRLFVHASA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000004579 taxol derivatives Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310501147.4A CN103508984B (zh) | 2013-10-22 | 2013-10-22 | 连续浸漉吸附富集法从红豆杉中提取10-dab的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310501147.4A CN103508984B (zh) | 2013-10-22 | 2013-10-22 | 连续浸漉吸附富集法从红豆杉中提取10-dab的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103508984A CN103508984A (zh) | 2014-01-15 |
CN103508984B true CN103508984B (zh) | 2017-03-08 |
Family
ID=49892465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310501147.4A Expired - Fee Related CN103508984B (zh) | 2013-10-22 | 2013-10-22 | 连续浸漉吸附富集法从红豆杉中提取10-dab的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103508984B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104059034A (zh) * | 2014-06-06 | 2014-09-24 | 庞作仁 | 超声波逆流无毒提取紫杉醇的生产***及工艺 |
CN105085443A (zh) * | 2015-09-21 | 2015-11-25 | 四川农业大学 | 一种以曼地亚红豆杉枝叶为原料制备高纯度10-脱乙酰基巴卡亭ⅲ的方法 |
CN106397371A (zh) * | 2016-08-31 | 2017-02-15 | 重庆市碚圣医药科技股份有限公司 | 一种用曼地亚红豆杉高产10‑dabⅲ的方法 |
CN107880001B (zh) * | 2017-12-28 | 2020-06-23 | 云南汉德生物技术有限公司 | 一种从红豆杉中提取10-去乙酰基巴卡亭ⅲ的方法 |
CN108822062B (zh) * | 2018-09-07 | 2020-08-28 | 无锡紫杉药业有限公司 | 一种多西他赛的精制方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0663909B1 (fr) * | 1992-10-05 | 1997-01-08 | Aventis Pharma S.A. | Procede d'obtention de la desacetyl-10 baccatine iii |
CN1538963A (zh) * | 2001-07-05 | 2004-10-20 | 拿坡罗生物治疗股份有限公司 | 通过选择性肼解多种紫杉烷制备10-d abⅲ的有效方法 |
CN1660827A (zh) * | 2004-12-27 | 2005-08-31 | 梅县梅雁生物工程研究所 | 从红豆杉枝叶中初分离10-去乙酰基巴卡亭ⅲ的方法 |
CN101230053A (zh) * | 2007-12-04 | 2008-07-30 | 北京诺瑞医药技术有限公司 | 从红豆杉枝叶中超声提取分离10-去乙酰基巴卡汀ⅲ的方法 |
CN103319441A (zh) * | 2013-06-17 | 2013-09-25 | 江苏红豆杉药业有限公司 | 一种从红豆杉枝叶中分离提纯10-去乙酰基巴卡亭ⅲ的方法 |
-
2013
- 2013-10-22 CN CN201310501147.4A patent/CN103508984B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0663909B1 (fr) * | 1992-10-05 | 1997-01-08 | Aventis Pharma S.A. | Procede d'obtention de la desacetyl-10 baccatine iii |
CN1538963A (zh) * | 2001-07-05 | 2004-10-20 | 拿坡罗生物治疗股份有限公司 | 通过选择性肼解多种紫杉烷制备10-d abⅲ的有效方法 |
CN1660827A (zh) * | 2004-12-27 | 2005-08-31 | 梅县梅雁生物工程研究所 | 从红豆杉枝叶中初分离10-去乙酰基巴卡亭ⅲ的方法 |
CN101230053A (zh) * | 2007-12-04 | 2008-07-30 | 北京诺瑞医药技术有限公司 | 从红豆杉枝叶中超声提取分离10-去乙酰基巴卡汀ⅲ的方法 |
CN103319441A (zh) * | 2013-06-17 | 2013-09-25 | 江苏红豆杉药业有限公司 | 一种从红豆杉枝叶中分离提纯10-去乙酰基巴卡亭ⅲ的方法 |
Non-Patent Citations (1)
Title |
---|
利用红豆杉枝叶及废料制备10-去乙酰基巴卡亭Ⅲ的研究;杨陶;《万方学位论文全文数据库》;20060425;正文第21-22页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103508984A (zh) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109942380B (zh) | 一种利用高速逆流色谱分离纯化制备***二酚的方法 | |
CN103508984B (zh) | 连续浸漉吸附富集法从红豆杉中提取10-dab的方法 | |
CN101190258A (zh) | 富含小白菊内酯的总倍半萜内酯提取物及其制备方法和应用 | |
CN105001052B (zh) | 烟草花序中提取西柏烷二萜的方法 | |
CN105294623B (zh) | 一种倍半萜内酯类化合物、其制备方法以及应用 | |
CN105061456A (zh) | 一种新的贝壳杉烷类二萜化合物及其制备方法和医药用途 | |
CN103408512A (zh) | 一种从红豆杉中高效提取紫杉烷类有效成分的方法 | |
CN105503807B (zh) | 一种名为表儿茶素反式咖啡酸酯的儿茶素类衍生物及其制备方法和应用 | |
CN105503786B (zh) | 裂木脂素类化合物—荨麻裂环木脂素苷e及其制备方法 | |
CN108299453B (zh) | 一种从补骨脂中分离补骨脂素、异补骨脂素和补骨脂酚的方法 | |
CN104892713B (zh) | 葫芦素c及其类似物的制备方法与应用 | |
CN103073561B (zh) | 一种生物酶-渗漉法提取青蒿素的工艺 | |
CN100404520C (zh) | 从欧洲红豆杉枝叶中提取分离10-去乙酰基巴卡汀ⅲ的方法 | |
CN102295651A (zh) | 一种银杏叶中总黄酮和总内酯的提取分离方法 | |
CN102258094B (zh) | 一种含天然植物或天然植物提取物的茶饮品及其制备方法和用途 | |
CN104177355A (zh) | 一种莨菪碱的提取方法 | |
CN104592185B (zh) | 荸荠皮提取槲皮素的方法 | |
CN110386861A (zh) | 从工业***里提取***二酚的新型工艺方法 | |
CN102311467A (zh) | 一种从结香中提取分离高纯度银椴苷的新方法 | |
CN102827106A (zh) | 一种10-dab的提取纯化方法 | |
CN102178725B (zh) | 黄花草木犀总皂苷及其制备方法和药物用途 | |
CN108101869A (zh) | 一种天然紫杉醇的提取方法 | |
CN103588736B (zh) | 13-乙酰基-9-羟基巴卡亭iii的提取分离方法 | |
CN102755276B (zh) | 降香香水 | |
CN105218605B (zh) | 提取分离海州香薷中假荆芥属苷、高车前苷和芹菜素糖苷的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Tiger Inventor after: Han Jiansheng Inventor after: Li Xu Inventor before: Han Jiansheng Inventor before: Li Xu |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170215 Address after: 100012 Beijing city in Chaoyang District Lize Park Building No. 106 (Wangjing District Office No. 078) Applicant after: Beijing Nuorui Medicine Technology Co.,Ltd. Address before: 100088 Beijing city Xicheng District xinjiekouwai Street No. 8 Building 12, No. 207 (Desheng Park) Applicant before: Beijing Harmony Chemical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170705 Address after: 100012, room 21, 401-9 torch street, Changping District science and Technology Park, Beijing Patentee after: BEIJING NOZER BIOTECHNOLOGY Co.,Ltd. Address before: 100012 Beijing city in Chaoyang District Lize Park Building No. 106 (Wangjing District Office No. 078) Patentee before: Beijing Nuorui Medicine Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
DD01 | Delivery of document by public notice |
Addressee: Liang Ke Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171208 Address after: 226499 Zhujianglu Road 888 (High-tech Zone life and Health Industrial Park), dug Port Street, Rudong County, Nantong, Jiangsu Patentee after: JIANGSU BAIRUI BIOMEDICAL TECHNOLOGY CO.,LTD. Address before: 100012, room 21, 401-9 torch street, Changping District science and Technology Park, Beijing Patentee before: BEIJING NOZER BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180801 Address after: 679199 No. 159, tea garden community, Shan Yuan community, Tengchong City, Baoshan, Yunnan Patentee after: Yunnan lorry Biotechnology Co.,Ltd. Address before: 226499 Zhujianglu Road County, Rudong, Nantong, Jiangsu, Zhujianglu Road No. 888 (hi tech Zone life and Health Industrial Park) Patentee before: JIANGSU BAIRUI BIOMEDICAL TECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170308 |
|
CF01 | Termination of patent right due to non-payment of annual fee |